Aside from its association with FAP, the distinction of CMTC from PTC is clinically relevant as the lack of unequivocal follicular cell differentiation questions the potential benefits of serum thyroglobulin measurements for tumor surveillance and RAI-related adjuvant therapies [55, 56]. Here, FAP is linked to neoplasm.